Abstract
The intersection of high blood pressure and diabetes creates a particularly hazardous health landscape, where their combined effects are far greater than the sum of their parts. When these two conditions form, it causes a pathway toward heart attacks, strokes, and kidney failure. This review examines the global health burden of cardiovascular diseases (CVDs) and their association with hypertension and diabetes, focusing on how these conditions contribute to increased cardiovascular and renal complications. Recent groundbreaking studies have revealed that certain diabetes medications, originally designed to lower blood sugar but provide remarkable protection for the heart and kidneys themselves. CVDs contribute to a significant global health burden, with disability-adjusted life years projected to rise from 153 million in 2010 to 187 million in 2030. Hypertension and diabetes, affecting 31.1% and 8.5% of the global adult population respectively, significantly escalate CVDs risks through mechanisms involving insulin resistance, vascular stiffness, and hypertension. Doctors' guidelines have been rewritten to reflect this new understanding, now prioritizing medications that offer this dual benefit. Yet there are many challenges remaining on the horizon, but the intricates interplay between hypertension, diabetes, and CVDs underscores the need for comprehensive therapeutic approaches, emphasizing effective hypertension management in diabetes through lifestyle adjustments and medication adherence to reduce cardiovascular and renal complications.